| Systematic (IUPAC) name | |
|---|---|
| 1-Ethyl-4-oxo-7-pyridin-4-ylquinoline-3-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 40034-42-2 |
| ATC code | J01MB01 |
| PubChem | CID 287180 |
| DrugBank | DB00817 |
| ChemSpider | 253208 |
| UNII | 3Y1OT3J4NW |
| KEGG | D02305 |
| ChEMBL | CHEMBL291157 |
| Chemical data | |
| Formula | C17H14N2O3 |
| Mol. mass | 294.30 g/mol |
| |
|
Rosoxacin (also known as acrosoxacin, tradename Eradacil) is a quinolone antibiotic indicated for the treatment of urinary tract infections and certain sexually transmitted diseases. Rosoxacin is not available in the United States.
It was developed by Sanofi-Synthelabo (now part of sanofi-aventis).
It is classified as first generation.[1]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)